Study of Ataluren in Participants With Nonsense Mutation Aniridia (Q63813343)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Study of Ataluren in Participants With Nonsense Mutation Aniridia
clinical trial

    Statements

    STAR (English)
    0 references
    STAR: A Phase 2, Multicenter, Randomized, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Ataluren (PTC124) for the Treatment of Nonsense Mutation Aniridia (English)
    0 references
    0 references
    0 references
    31 January 2016
    0 references
    21 February 2022
    0 references
    39
    0 references
    2 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit